WeLeader Biomedical Co., Ltd. (7713.TWO)

TWD 55.6

(1.09%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020
Revenue 940.69 Million 1.03 Billion 841.14 Million 674.54 Million
Cost of Revenue 642.62 Million 743.97 Million 622.21 Million 517.94 Million
Gross Profit 298.07 Million 291.74 Million 218.92 Million 156.59 Million
Operating Expenses 100.59 Million 97.63 Million 86.26 Million 88.62 Million
Selling, General and Administrative Expenses 100.59 Million 97.63 Million 86.26 Million 17.73 Million
Research and Development Expenses - - - 3.99 Million
Other Expenses 682 Thousand 1.88 Million 5.27 Million 1.23 Million
Cost and Expenses 743.21 Million 841.6 Million 708.47 Million 606.57 Million
Operating Income 198.75 Million 196.22 Million 132.27 Million 68.55 Million
Interest Expense 5.69 Million 4.2 Million 6.16 Million 8.59 Million
Income Tax Expense 41.26 Million 38.74 Million 25.68 Million 12.19 Million
Earnings before Tax 193.54 Million 192.54 Million 131.45 Million 61.27 Million
Net Income 152.28 Million 153.79 Million 105.77 Million 49.07 Million
Earnings Per Share Basic 4.36 4.40 3.79 1.18
Earnings Per Share Diluted 3.66 4.34 3.76 1.18
Weighted Average Shares Outstanding 34.95 Million 34.95 Million 27.88 Million 41.57 Million
Weighted Average Shares Outstanding (Diluted) 41.57 Million 35.43 Million 28.1 Million 41.57 Million
Gross Margin 0.32 0.28 0.26 0.23
EBIT Margin 0.32 0.30 0.30 0.26
Profit Margin 0.16 0.15 0.13 0.07
EBITDA 303.03 Million 306.57 Million 252.06 Million 179.22 Million
Earnings Before Tax Margin 0.21 0.19 0.16 0.10

Income Statement Charts